4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Baijin Life Science Holdings Limited (1466) operates in the Luxury Goods industry and is headquartered in Wan Chai, Hong Kong with about 84 employees. Its market capitalization is roughly HKD 951 million. In the fiscal year ended 2026-03-31, 1466 reported HKD 89M in revenue and (HKD 38M) in net income.
Baijin Life Science Holdings Limited, an investment holding company, engages in the purchase, processing, design, production, assembly, trading, and wholesale distribution of jewelry products. The company operates through three segments: Jewellery Business, Strategic Investment, and Skincare Business.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | HKD 89M | HKD 136M | HKD 54M | HKD 87M | — |
| Gross Profit | HKD 7M | HKD 42M | HKD 18M | HKD 8M | — |
| Operating Income (EBIT) | (HKD 47M) | HKD 6M | (HKD 10M) | HKD 11M | — |
| Net Income | (HKD 38M) | (HKD 0M) | (HKD 7M) | HKD 9M | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | HKD 264M | HKD 290M | HKD 197M | HKD 100M | — |
| Total Liabilities | HKD 72M | HKD 134M | HKD 84M | HKD 22M | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1466 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms